Frontiers Production Office. (2023). Erratum: Stylopine: A potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers Media S.A..
Chicago Style (17th ed.) CitationFrontiers Production Office. Erratum: Stylopine: A Potential Natural Metabolite to Block Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) in Osteosarcoma Therapy. Frontiers Media S.A., 2023.
MLA (9th ed.) CitationFrontiers Production Office. Erratum: Stylopine: A Potential Natural Metabolite to Block Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) in Osteosarcoma Therapy. Frontiers Media S.A., 2023.
Warning: These citations may not always be 100% accurate.